FDA Approves Benralizumab to Treat Pediatric Patients Aged 6 to 11 Years With Severe Asthma
Benralizumab was previously approved by the FDA in 2017 as an add-on maintenance therapy for patients 12 years and older.
Source: pharmacytimes.com
Long Term Safety Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Long Term Safety Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Long Term Safety Study Today - Breaking & Trending Today
The Week in Review: September 11-15
From the efficacy of adjunctive TMS for treatment-resistant major depression to a look at adult ADHD, here are highlights from the week in Psychiatric Times.
Source: psychiatrictimes.com
Study Supports Long-Term Efficacy of Esketamine Nasal Spray in Patients With TRD
Investigators noted sustained improvement in depressive symptoms for up to 6.5 years.
Source: psychiatrictimes.com
AbbVie to Showcase Breadth of Neuroscience Portfolio and Pipeline at American Academy of Neurology (AAN) 2022 Annual Meeting
-- AbbVie to present 30 abstracts demonstrating its leadership in neuroscience, including continued migraine treatment research across the spectru...
Source: businessinsider.com
Neurelis Announces 16 Poster Presentations at the Annual Meeting of the American Epilepsy Society
/PRNewswire/ -- Neurelis, Inc. will present a collection of 16 posters describing safety, tolerability and effectiveness results observed in trials evaluating...
Source: prnewswire.com